What is microdosing, why do people microdose and what is the evidence for its effect? A new "self blind experiment" will be presented and preliminary data from a prospective online study from Imperial College will be shown and discussed.




The "self-blind experiment" is part of the Beckley/Imperial Research Programme.


David graduated as a medical doctor from Copenhagen University Medical School in 2001 and currently holds an Academic Clinical Lecture in Psychiatry at Imperial College London. In addition to his clinical training in medicine/psychiatry, David has been involved in psychopharmacological research, using imaging techniques such as PET and MRI.

Initially working at Columbia University in New York, he went on to complete his PhD at the University Hospital Rigshospitalet in Copenhagen. Since 2009, under the supervision of Profs Anne Lingford-Hughes and David Nutt, he has conducted post-doc imaging research in the neurobiology of addiction and major depression at Imperial College London. Together with Prof Nutt and Dr Carhart-Harris, he is also investigating the neurobiology and therapeutic potential of MDMA and classical psychedelics.